Compare MRBK & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRBK | ACB |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 227.2M | 232.3M |
| IPO Year | 2018 | 2016 |
| Metric | MRBK | ACB |
|---|---|---|
| Price | $19.10 | $4.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $20.75 | N/A |
| AVG Volume (30 Days) | 55.0K | ★ 754.7K |
| Earning Date | 04-23-2026 | 06-17-2026 |
| Dividend Yield | ★ 3.05% | N/A |
| EPS Growth | ★ 30.34 | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $6,316,000.00 | N/A |
| Revenue This Year | $25.40 | $6.31 |
| Revenue Next Year | $8.15 | N/A |
| P/E Ratio | $29.56 | ★ N/A |
| Revenue Growth | ★ 10.13 | N/A |
| 52 Week Low | $13.81 | $2.56 |
| 52 Week High | $21.59 | $6.67 |
| Indicator | MRBK | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 37.94 | 59.25 |
| Support Level | $18.58 | $3.27 |
| Resistance Level | $20.77 | $4.15 |
| Average True Range (ATR) | 0.42 | 0.13 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 1.48 | 59.68 |
Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.